Vitamin Shoppe (VSI) Receives Daily Coverage Optimism Rating of 0.11

Press coverage about Vitamin Shoppe (NYSE:VSI) has trended somewhat positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vitamin Shoppe earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned news stories about the specialty retailer an impact score of 47.1465367858668 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

Several analysts recently weighed in on VSI shares. Zacks Investment Research upgraded Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Morgan Stanley decreased their price objective on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a report on Thursday, November 9th. Finally, Barclays decreased their price objective on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a report on Thursday, November 9th. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $5.00.

Shares of Vitamin Shoppe (NYSE VSI) opened at $5.25 on Tuesday. The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $125.88, a PE ratio of -0.50 and a beta of 0.68. Vitamin Shoppe has a fifty-two week low of $2.95 and a fifty-two week high of $23.85.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The company had revenue of $288.20 million during the quarter, compared to analysts’ expectations of $297.61 million. During the same quarter last year, the firm earned $0.50 EPS. Vitamin Shoppe’s revenue for the quarter was down 8.5% on a year-over-year basis. research analysts anticipate that Vitamin Shoppe will post 0.34 EPS for the current fiscal year.

In related news, major shareholder Vintage Capital Management Llc bought 326,692 shares of the business’s stock in a transaction on Friday, January 5th. The shares were bought at an average price of $4.96 per share, for a total transaction of $1,620,392.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 694,839 shares of company stock worth $3,214,809 in the last quarter. 1.07% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Insider Buying and Selling by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply